This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
SEE YOU NEXT YEAR: May 7-10, 2023 | In-Person + Digital
San Diego, CA, USA

Joe Guiles, PhD
Head of Development - Nucleic Acid Solution Divis at Agilent Technologies


Joe is a Pharma/Biotech senior leader with extensive experience in building and leading technical functions that focus on clinical and commercial stage therapeutic API’s. He is currently the Head of Development at Agilent Technologies Nucleic Acid Solution Division in Boulder, CO. His past employers included Medivation, Cedarburg-Hauser, Replidyne, Sanofi-Aventis, and Johnson & Johnson.

Agenda Sessions

  • Gram-Scale Good Manufacturing Practice (GMP) Single Guide RNA for CRISPR-based Gene Editing